Parexel CEO sells $2.4M in stock
Parexel CEO Josef Von Rickenbach unloaded 50,000 shares of stock last Friday.
Archives for February 12, 2014
Amgen plant hit with US FDA Warning over Enbrel combination product
The US Food and Drug Administration (FDA) has issued Amgen with a Warning Letter at its Thousand Oaks, California plant citing violations in the production of monoclonal antibody combination products.
MPI Research, 3D Imaging and inviCRO team up for imaging centre
MPI Research, inviCRO and 3D Imaging have partnered to build a Translational Imaging Center, providing molecular imaging, autoradiography, and animal modelling for pharmaceutical clients to investigate drug candidates.
Theorem, Decision Driver form strategic alliance
Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics (DDA) to integrate health economics and outcomes research, predictive modeling and definitive analysis to maximize return on investment for...
CRL to close MI research model unit, as preclinical biz blossoms
Charles River Laboratories says it will shutter a Research Models and Services (RMS) facility in Michigan as softened demand for the sector offset a strong year for its preclinical service business.
Irish manufacturing and all that Jazz!
Jazz Pharmaceuticals has begun construction on a manufacturing facility in Ireland a month after acquiring a late stage narcoleptic compound.
Cobra attains QC testing accreditation at Swedish plant
Cobra says it will no longer need to rely on third-parties for its biologics quality control tests after receiving an extension to its GMP certification at a Swedish facility.
Changes proposed to US CFATS facility security rules
It is too early to predict what impact proposed changes to US rules on chemical plant security and anti-terrorism measures would have on the drug industry according to PhRMA.